Phlow raises funds to expand its CDMO capabilities
The CDMO completes a Series B capital raise, and it will use the funds generated to broaden its commercial offerings through its cdmoX program.
The CDMO completes a Series B capital raise, and it will use the funds generated to broaden its commercial offerings through its cdmoX program.
Dutch biopharmaceutical company, Pharming Group PV, has sent its first commercial shipments of a drug to treat a rare, primary immunodeficiency, to the US.
A stand alone drug for people living with depression and anxiety has been patented by biopharmaceutical company, Vistagen.
A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the world’s largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.